echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Control asthma Eight myths to be aware of

    Control asthma Eight myths to be aware of

    • Last Update: 2020-11-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Bronchial asthma (asthma) is a common, heterogeneous, serious risk to human health of chronic airway inflammatory diseases. The heavier this level of inflammation in the respiratory tract, the more difficult it is to breathe normally. Failure to take any anti-inflammatory measures can result in blocked bronchial tubes or contractions, and may even be life-threatening due to breathing difficulties. Lin Jiangtao, head of the China Asthma Alliance, stressed the importance of standardized treatment and self-management as a preventable and controllable disease. Asthma patients should continue to use asthma medications as usual, even during an outbreak.
    research shows that although the level of asthma control in China has improved significantly in recent years, 71.5% of patients still fail to control asthma, which is still far from the goal of "achieving and maintaining clinical control of asthma" proposed by GINA. It is precisely because of the misunderstanding of asthma diagnosis and treatment that the goal of GINA asthma management is hindered.all asthma symptoms as bronchial asthma, which is not uncommon in clinical practice. In addition to bronchial asthma, such as acute and chronic left heart insexuality, spontaneous gas chest, chronic obstructive pulmonary disease (COPD), allergic bronchial pulmonary pulmonary mildew disease (ABPA), benign/malignant tumors in the trachea, acidophilic pulmonary disease, allergic vasculitis and other diseases, may appear asthma symptoms. Clinical guidelines should be based on the guidelines, after formal treatment, poor efficacy of asthma patients, should be vigilant, do a good job of identification and diagnosis. Select the necessary auxiliary tests, such as lung function, fibre mirror, chest, chest and secondary sinus CT, bronchial diassis test/excitation test, noninvasive airway inflammation test, etc., with a view to accurate diagnosis.to achieve asthma control goals requires comprehensive management, involving health care, patients, families and society, medicines, the environment (allergens, smoking) and other factors. Studies have shown that asthma management can improve compliance and asthma control rates in asthma patients, patient management can help reduce the number of asthma emergency, the correct use of inhalation devices and standardized medications can help patients improve asthma control levels.
    Asthma management requires the following: 1. Building a doctor-patient partnership; 2. Identifying and reducing the factors that cause asthma in exposure; 3. Assessing, treating and monitoring asthma; 4. Management of acute asthma exacerbation; and 5. Diagnosis and treatment of special types of asthma.patients and their families want to "cure" asthma, expectations are too high, some doctors think that "no rule of law" and lack of confidence. Some ungrands, under the banner of "the ancestral cure for asthma unilaterally", illegally produced and sold anti-asthma drugs laced with glucodermal hormone powder, making a profit. GINA's definition of asthma emphasizes that asthma is preventable and treatable. Medical workers are called upon to actively communicate with patients, from the patient's psychological point of view, to expose the harm of counterfeit drugs, so that patients receive formal treatment;doctors and asthma sufferers use inhaled glucoticoids (ICS) as a drug to relieve acute asthma symptoms, hoping to alleviate asthma symptoms immediately. Because it did not achieve the desired purpose, it came to the wrong conclusion that "inhalation hormone efficacy is not good". Many asthma sufferers and their families, especially young women, are reluctant to use ICS because of concerns about the side effects of hormones. ICS is not used as a basis for asthma treatment and as a first-line drug.
    bronchial asthma is a disease characterized by chronic airway inflammation, which requires longer-term maintenance of treatment, and inhalation of glucoticoid therapy based on airway inflammation can reduce the acute exacerbation of asthma. In the course of anti-inflammatory treatment, there are problems such as inadequate treatment, improper drug selection, insufficient dose and short course of treatment. In clinical work, medical staff should help patients realize that asthma is a disease characterized by chronic airway inflammation, ICS is the first-line basic drugs to control asthma, let patients understand the respective characteristics of relief drugs and control drugs and different methods of use, help patients understand the safety and importance of ICS, overcome the fear of ICS, receive standardized treatment.as a chronic disease, the vast majority of the time during the course of the disease is the patient's own medication. Therefore, the patient's compliance is the key to determine the efficacy of bronchial asthma. Poor compliance is a major problem in asthma management. The effect of improved compliance on health prognosmation is far greater than changing a particular treatment.
    doctors in clinical work, as long as the patient to find the reasons for poor compliance, can be solved. In view of the patient's lack of understanding of the disease, do not understand the drug use program and inhalation techniques, patients do not understand the health benefits, etc. , need patience and full education;
    improve the patient's compliance work points: repeated, adequate education, active treatment, after the initial diagnosis to obtain obvious efficacy, timely understanding of the patient's real thoughts, concerns, targeted persuasion work, treatment of successful asthma patients demonstration role.Causes of overuse of antibiotics in asthma patients: 1. Misconsuming the upper respiratory tract virus infection that induces an asthma attack as a bacterial infection; 2. Mistaking yellow sputum caused by an increase in acidophilic cells for a septic bacterial infection; 3. Treating chest X-rays in acute asthma attacks as "lung infections"; 4. Attempting to prevent asthma attacks with antibiotics. Asthma patients abuse antibiotics is very harmful, easy to lead to misdiagnosis, induce the selection of drug-resistant bacteria, increase medical costs and cause drug asthma.
    We need to have a rigorous grasp of the evidence of antibiotic use: 1. asthma caused or exacerbated by sub-sinusitis; 2. Severe asthma attacks; 3. Hormone-dependent asthma patients reduce hormone use.Asthma incidence is closely related to environmental factors, environmental factors cause susceptible individuals to develop asthma, or induce symptoms, or aggravate/sustain symptoms, and actively identify allergens or other wheezing factors associated with an asthma attack in a specific patient, which is important for the prevention and treatment of the disease. Asthma patients with some asthmatic factors, as long as they can effectively avoid re-contact, can receive "no medicine and cure" comedy effect. Asthma incidence related to common allergies of the original dust mites (house dust mites, dust mites), pollen (artemisinin grass, guinea grass, etc.), mold, cockroaches, rat urine, silk, toluene isocyanate (TDl) may also induce asthma.
    In addition to asking about medical history, medical personnel can also do on-site investigation if necessary, laboratory examination to do allergen skin test, bronchial excitation test, in-body test, for the treatment of "ineffective" cases according to GINA program, should not blindly "upgrade treatment", should first check whether environmental control is doing well.Clinically, the lung function examination project and interpretation results were not selected correctly, when the expected value of FEV1 (one second force exhalation volume) ≥70%, bronchial excitation test assessed gas channel reactive;
    (Yin Kaisheng, Chief Physician, Respiratory Department, First Affiliated Hospital, Nanjing Medical University)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.